The mixed cryoglobulinemia is considered to be a nonmalignant human B-cell proliferation that frequently produces a monoclonal IgM with anti-IgG activity (rheumatoid factor). Using murine monoclonal anti-idiotypic antibodies specific for private -minor idiotopes on monoclonal IgM from three patients , ing from nonmalignant mixed cryoglobulinemia, t.
HE PRODUCTION OF monoclonal IgM rheumatoid
T factors (RF) in humans can be observed during two different clinical situations: one is malignant, the Waldenstrom macroglobulinemia where the monoclonal component has an anti-Fc activity; the other is presumed nonmalignant, the mixed cryoglobulinemia where the monoclonal R F is part of the cryoprecipitate. The majority of knowledge concerning the structure of human RFs comes from the study of these monoclonal RFs. In particular, it was shown that the majority of the monoclonal RFs from unrelated individuals expresses cross-reactive idiotopes (CRI) and use selected VK genes. '-3 Recently, similarities were described between the mixed cryoglobulinemia and a malignant human B lymphoproliferation, the B chronic lymphocytic leukemia (B-cell CLL). It was shown that the B-cell CLL cells rearrange with a high frequency the same VK gene as monoclonal R F secreting cells4 and that this VK use is not subjected to somatic mutation? On the other hand, it was also demonstrated that the monoclonal IgM R F synthesis is idiotypically stable over a prolonged period of time during mixed cryoglobulinemia leading to the proposal that the monoclonal R F variable regions were not subjected to somatic mutations during the course of this disease.6 To complete the comparison, and because the BCLL are known to express the CD5 membrane antigen, it was interesting to look for the presence of the CD5 antigen on the B-cell proliferation responsible for the IgM R F synthesis during mixed cryoglobulinemia. Using monoclonal anti-idiotypic antibodies specific for private or minor idiotopes on three different monoclonal IgM RFS from patients suffering from nonmalignant mixed cryoglobulinemia, we demonstrated by twocolor cytofluorometric analysis that the majority of the peripheral blood monoclonal IgM R F secreting cells is CD5 negative.
MATERIALS AND METHODS
Patients. Alt, Fel, and Bul are three unrelated patients suffering from nonmalignant mixed cryoglobulinemia. Clinically there was no evidence of a malignant proliferation after 5 years (Alt), 3 years (Fel), and 6 years (Bul) of follow-up and treatment with repeated plasmapheresis. The three monoclonal IgM K had an anti-IgG activity (rheumatoid factor [RF] ).
Murine monoclonal antibodies (MoAbs) specific for private idiotopes on Alt IgM R F and
Monoclonal anti-idiotypic antibodies.
the monoclonal rheumatoid factor K variable regions was sequenced at the protein level and belongs to the human VK 111 group, as a high proportion of monoclonal rheumatoid factors and some B-cell chronic lymphocytic leukemia (CLL) membrane bound Igs. Thus, despite the preferential use of similar VK genes and the absence of somatic mutation affecting these variable regions in both malignant B-cell CLL and nonmalignant mixed cryoglobulinemia, these proliferating B cells differ in the CD5 membrane expression. o 1991 by The American Society of Hematology.
Fel IgM R F were used in this study. A75 is a murine IgGl MoAb specific for a light chain associated idiotope on Alt IgM RF.' FIV3.3 is a murine IgGl MoAb that was produced as previously d e s~r i b e d~.~ after immunizing mice with purified Fel IgM RF. 311 2.1 is a murine monoclonal anti-idiotope that was produced by immunizing a mouse with polyclonal RF"; it reacts with a low proportion of polyclonal R F and with Bul monoclonal RF. Thus, it recognizes a minor idiotope of RF. Fab', of the MoAbs were prepared after digestion with pepsin (Sigma, St Louis, MO) as described" and purified over a protein A-affinity column (Bio Rad MAPS 11) following the manufacturer's instructions.
Enzyme-linked immunosorbent assays (ELISA). Reactivity of MoAhs with the RFs was established by both direct assay and inhibition of binding assay.'.' Briefly, during the direct assay, plastic microtiter wells (NUNC) were coated with purified RFs or control proteins (10 pg/mL). After blocking the remaining active sites with 1% bovine serum albumine phosphate-buffered saline (BSA-PBS), the purified MoAbs (1 pg/mL) were added and incubated for 1.5 hours at 37°C. After washing with PBS, binding of the MoAbs was measured by adding peroxidase labeled affinity purified goat anti-mouse IgG (0.5 pg/mL; Jackson Immunoresearch Labs, Bar Harbor, ME) followed by washings of the peroxidase substrate (Sigma).
Inhibition of antigen binding was performed as described? Briefly, microtiter wells were coated with purified human IgG (50 pg/mL). The remaining active sites were blocked with 1% BSA-PBS. Mixtures of the MoAbs (1 pg/mL) and IgM R F (400 ng/mL) were prepared and incubated for 1 hour at room temperature. These mixtures were then added to the IgG coated microtiter wells. After a 1.5-hour incubation at 37°C and washings with PBS, binding of IgM R F was measured by adding peroxidase-labeled affinity purified goat anti-IgM (Cappel, Malvern, PA) in T-PBS (1 For personal use only. on November 15, 2017. by guest www.bloodjournal.org From @mL, 1 hour at 37°C) followed by washings of the peroxidase substrate (Sigma).
The effect of the anti-id MoAb on R F binding was expressed as a percentage of the initial R F activity, ie, binding activity with MoAb control % inhibition'= 100 -x 100
The control was a mixture of the supernatant and an unrelated MoAb of the same subclass. Each assay was done in duplicate.
Cytofuorometric analysis of cells. About 2 x los peripheral blood mononuclear cells were incubated 15 minutes at 4°C with purified Fab', fragments of FIV 3,3 (10 pg/mL) or A75 (10 pLg/mL) or BII 2.1 (10 &mL), then centrifuged and washed twice in FACS wash (PBS; 3% heat inactivated fetal calf serum; 0.1% sodium azide; 30 mmoVL Hepes). The presence of the anti-idiotopes was shown by a fluorescein conjugated Fab', fragment of rabbit anti-mouse IgG (Fab', fragment specific; Jackson) 15 minutes at 4°C.
For the double staining experiments, the cells were then washed in FACS wash, saturated with normal purified murine IgG, then incubated with a murine, monoclonal biotin labeled anti-human CD5 (Becton Dickinson, Mountain View, CA) 15 minutes at 4°C. Cells were then washed twice in F A G wash and identified by Avidin Texas Red. Cells were washed again and fixed with 1% paraformaldehyde in PBS. Fluorescence was analyzed on an ODAM ATC 3000 (Wissembourg, France), and fitted with logarithmic amplifiers.
The amino acid sequence of Alt K chain was established by sequencing tryptic and chymotryptic fragments. The sequences of known K-chains were used as a template for final alignment of the various peptides. Purified K chains were obtained after treatment of Alt IgM RFwith mercapto ethanol as described. ' Samples of Alt K chains (5 to 10 nmol) were subjected to tryptic or chymotryptic hydrolysis in 50 mmol/L ammonium bicarbonate at 37°C for 2 to 3 hours (enzymembstrate ratio 150). Resulting peptides were separated by high pressure liquid chromatography on a reversed phase column C-8, Lichrospher 100 CH-8, 10 pm (Merck Darmstadt, Germany) with a linear acetonitrile gradient in 0.05% trifluoroacetic acid. Purified peptides were first characterized by their amino acid composition and then sequenced manually using the dimethyl amino azobenzene isothiocyanateiphenylisothiocyanate t e c h n i q~e . '~~'~ Protein sequencing ofAlt VK.
RESULTS AND DISCUSSION
A75, FIV 3,3 and BIT 2.1 are anti-idiotypic antibodies specific for idiotopes on Alt, Fel, and Bul TgM RFs. Table 1 shows the results of the ELISA (direct and inhibition of binding) obtained with the Fab'2 of the MoAbs. MoAbs A75 and FIV 3.3 do not recognize cross-reactive determinants on monoclonal IgM RFs, and they do not react with pooled polyclonal IgM or IgG. Both are able to inhibit the binding of their respective IgM R F with solid phase IgG. BII 2.1 recognizes Bul IgM RF even though it was produced against unrelated polyclonal RF.'" Purified Fab', fragments of A75, FIV 3,3 and BII 2.1 were subsequently used for the cytofluorometric analysis as they were considered to be specific markers of Alt, Fel, and Bul IgM RF, respectively. For our purpose, the use of anti-cross-reactive idiotope reagents was unsuitable because these antibodies frequently react with a low proportion of non-RF Ig.
Peripheral blood mononuclear cells contain membrane idiotopepositive cells. As previously shown, patients' peripheral blood contains the monoclonal Ig secreting cells during mixed cry~globulinemia.~~'~ Using the anti-idiotypic MoAbs, we show that membrane idiotope positive cells are consistently detectable, either at a low frequency (0.7% to 1%) in two patients' peripheral mononuclear cells (Alt and Fel ,   Fig l) , or at a higher frequency (Bul, 3% to 4%). Control experiments using an unrelated Fab', of murine IgGl showed less than 0.2% of weakly positive cells (data not shown).
The majority of the idiotope positive cells is CD5 negative. Using a two-color cytofluorometric analysis, we show that the majority of the Alt, Fel, and Bul idiotope positive cells do not contain a significant amount of the CD5 membrane marker (Fig 2A and B One could argue that the three monoclonal IgM RFs studied in these patients might be peculiar in using an unusual set of Alt IgMRF uses a VK IZI light chain sequence. variable region genes. Two of these three monoclonal RFs (Alt and Fel) express a cross-reactive idiotope that is present in approximately 30% of the monoclonal IgM RF seen in mixed cryoglobulinemia, and is recognized by a murine MoAb F V 1,l (unpublished results). Moreover, we performed the protein sequence of Alt IgM RF VK to compare this sequence with known human IgM RF VK primary sequences. Table 2 shows that Alt VK belongs to the VK I11 family with almost 90% homology with the prototype sequences Les IgM RF and Pom IgM RF (VK IIIa sub subgroup). Thus, at least for the VK use, Alt IgM RF does not appear to be peculiar among the human monoclonal IgM RFs. The germ line gene (VK 328) encoding the Les K chain has been cloned and sequenced from malignant B-cell CLL cells. '5 However, the Les B-cell CLL was recently reported as being distinct from classical B-cell C L L the "Les" is a CD5 negative CLL and is subjected to intraclonal diversity in its expressed VH genes.I6 Even though Alt IgM RF is idiotypically stable over a prolonged period of time: the existence of such an intraclonal diversity in a CD5 negative B cell CLL deserves further evaluation at a genetic level of the homogeneity of the expressed Ig genes of mixed cryoglobulinemia cells.
Despite the fact that the classical malignant B cell CLL cells and IgM RF secreting cells from mixed cryoglobulinemia preferentially use similar VK regions: and that both the classical malignant B-cell CLL cells and the nonmalignant mixed cryoglobulinemia cells are apparently not affected by Ig variable region these two diseases differ at least by the clinical evolution and the CD5 expression of the proliferating cells. Is there any relationship between these two differences? One can propose different explanations: (1) The significance of the CD5 
